Drugmaker Shire bids $30 bn for Baxter spin-off Baxalta
Drugmaker Shire said on Tuesday it was seeking to buy Baxalta a company spun-off by Baxter International last month, for USD 30 billion to forge the leading global specialist in rare diseases.